Abstract
Productive infection with HIV-1 is mediated by fusion of the HIV-1 envelope with the cell membrane and subsequent entry of the virion core into the cytoplasm. The core is then rearranged to form the reverse transcription complex which is responsible for conversion of the genomic RNA to its double-stranded DNA copy. Various genetic, biochemical and microscopy studies have shed light on the role of viral proteins in the core in this process; Gag cleavage products, in particular, are crucial. It is also at this point that core is potentially exposed to the action of restriction factors such as TRIM5α and APOBEC3G, highlighting the vulnerability of this stage of the retrovirus life-cycle to the cells defenses. Rearrangement of the core may be an active process involving host-cell activities, although this is not clear, but may also be partly passive due to the instability of the structure. What regulates this process is unknown. Several host-cell kinase activities are important for replication and have been shown to be incorporated in the virion. We speculate that these kinases may regulate core rearrangement or the interaction of the reverse transcription complex/pre-integration complex with the cytoplasm. Recent real-time microscopy experiments with fluorescent-labeled probes suggest a model in which the virion utilizes the cytoskeleton for transport whilst in the cytoplasm. After entering the cell, the virion interacts initially with actin filaments which assist binding to microtubles enabling transport to the nuclear periphery. An actin-transport process may then facilitate the remaining short journey to the nuclear membrane.
Keywords: HIV, replication, reverse transcription, restriction factor, uncoating
Current HIV Research
Title: HIV-1 Replication from After Cell Entry to the Nuclear Periphery
Volume: 5 Issue: 3
Author(s): David Warrilow and David Harrich
Affiliation:
Keywords: HIV, replication, reverse transcription, restriction factor, uncoating
Abstract: Productive infection with HIV-1 is mediated by fusion of the HIV-1 envelope with the cell membrane and subsequent entry of the virion core into the cytoplasm. The core is then rearranged to form the reverse transcription complex which is responsible for conversion of the genomic RNA to its double-stranded DNA copy. Various genetic, biochemical and microscopy studies have shed light on the role of viral proteins in the core in this process; Gag cleavage products, in particular, are crucial. It is also at this point that core is potentially exposed to the action of restriction factors such as TRIM5α and APOBEC3G, highlighting the vulnerability of this stage of the retrovirus life-cycle to the cells defenses. Rearrangement of the core may be an active process involving host-cell activities, although this is not clear, but may also be partly passive due to the instability of the structure. What regulates this process is unknown. Several host-cell kinase activities are important for replication and have been shown to be incorporated in the virion. We speculate that these kinases may regulate core rearrangement or the interaction of the reverse transcription complex/pre-integration complex with the cytoplasm. Recent real-time microscopy experiments with fluorescent-labeled probes suggest a model in which the virion utilizes the cytoskeleton for transport whilst in the cytoplasm. After entering the cell, the virion interacts initially with actin filaments which assist binding to microtubles enabling transport to the nuclear periphery. An actin-transport process may then facilitate the remaining short journey to the nuclear membrane.
Export Options
About this article
Cite this article as:
Warrilow David and Harrich David, HIV-1 Replication from After Cell Entry to the Nuclear Periphery, Current HIV Research 2007; 5 (3) . https://dx.doi.org/10.2174/157016207780636579
DOI https://dx.doi.org/10.2174/157016207780636579 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer
Current Topics in Medicinal Chemistry MicroRNA and Bone Tumor: To Up Date
Current Signal Transduction Therapy Elucidating Protein-protein Interactions Through Computational Approaches and Designing Small Molecule Inhibitors Against them for Various Diseases
Current Topics in Medicinal Chemistry Identification of Genes Associated with Lung Adenocarcinoma Prognosis
Combinatorial Chemistry & High Throughput Screening Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Ambidextrous Cyclooxygenase: An Enduring Target
Inflammation & Allergy - Drug Targets (Discontinued) QSAR Models for Anti-Malarial Activity of 4-Aminoquinolines
Current Computer-Aided Drug Design The Potential of Tetrandrine Against Gliomas
Anti-Cancer Agents in Medicinal Chemistry Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy
Current Cancer Drug Targets Membrane Fusion and Fission: Enveloped Viruses
Protein & Peptide Letters Epigenetic MicroRNA Regulation of Multiple Chromatin Functions: A Perspective in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) AKT: A Potential Target for Thyroid Cancer Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders A New Interpretative Paradigm for Conformational Protein Diseases
Current Protein & Peptide Science Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Current Pharmaceutical Biotechnology Synthesis, in Vitro and in Vivo Anticancer Activity of Hybrids of 3- Hydroxy-indolin-2-one and 2,3-Dihydroquinolin-4(1H)-one
Letters in Drug Design & Discovery First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?
Current Gene Therapy ETS Proteins and MMPs: Partners in Invasion and Metastasis
Medicinal Chemistry Reviews - Online (Discontinued) Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Current Pharmaceutical Biotechnology Perspectives of Fullerenes, Dendrimers, and Heterocyclic Compounds Application in Tumor Treatment
Recent Patents on Nanomedicine